siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo.
about
siRNA and RNAi optimizationRNA mediated Toll-like receptor stimulation in health and diseaseNanomedicine therapeutic approaches to overcome cancer drug resistanceAntitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in MiceSilencing disease genes in the laboratory and the clinicImmunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.2'-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity.Involvement of activation of PKR in HBx-siRNA-mediated innate immune effects on HBV inhibition.Potent inhibition of Hendra virus infection via RNA interference and poly I:C immune activationImmunotherapy of hepatocellular carcinoma with small double-stranded RNA.RNA interference for the treatment of papillomavirus disease.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA.2'Fluoro Modification Differentially Modulates the Ability of RNAs to Activate Pattern Recognition Receptors.siRNA and cancer immunotherapy.Toll-like receptors in human papillomavirus infection.In vivo comparison of local versus systemic delivery of immunostimulating siRNA in HPV-driven tumours.Restoration of MAGI-1 expression in human papillomavirus-positive tumor cells induces cell growth arrest and apoptosis.A Simple and Cost-Effective Approach for In Vitro Production of Sliced siRNAs as Potent Triggers for RNAi.Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
P2860
Q26769738-C68D5F6E-98CC-4407-9F7F-B572E0937827Q26999252-5BBA15BD-4F37-44FF-A751-CA3169F87B60Q27011692-A25B7486-6925-4D9F-9219-BCA45FB9D539Q27318732-50E5CF28-8ED9-4D42-B267-EBC489C30CD4Q29039090-786B399A-E505-4B74-9CD6-129BF089344AQ33626347-FEBC73A7-0515-40E5-8F29-01BCBAA923C0Q33956803-057BCB81-0743-443A-BCFC-A652835C02EFQ34102905-199FD059-3131-420E-88A6-28517EC56C35Q34731475-71246D64-14CF-4D13-AEA8-F843D96B2097Q35179465-FC6BCFF7-A9EC-43C1-881E-F9FB9925D69FQ36540664-14A5C9CB-B7AB-4138-B5D3-83510199F048Q36807121-AB8B5CF1-4214-4C81-8A24-5CE5CEB6894AQ36968187-B4B8BE46-2C99-45C8-921D-4ACF7AE6A4F8Q36987499-6A4BB99B-93F5-45F2-B222-4FFE522A1910Q38050504-E248FCF3-53EE-4A07-98D6-7F13AE130F17Q38084160-1FFA657A-6C0F-4170-9D2C-268C5A9780C0Q39064359-6A485BAE-FCDB-409C-B53A-8DC4D4866C69Q40607486-67FFBC60-B997-4433-814E-5563D0EDEFF7Q41191245-053A0E1E-80DB-436A-9332-63BB745B728EQ43435087-261C5C30-02B5-42BD-BC14-05FBCFB2F1A4
P2860
siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
siRNA-induced immunostimulatio ...... nst HPV-driven tumors in vivo.
@en
siRNA-induced immunostimulatio ...... nst HPV-driven tumors in vivo.
@nl
type
label
siRNA-induced immunostimulatio ...... nst HPV-driven tumors in vivo.
@en
siRNA-induced immunostimulatio ...... nst HPV-driven tumors in vivo.
@nl
prefLabel
siRNA-induced immunostimulatio ...... nst HPV-driven tumors in vivo.
@en
siRNA-induced immunostimulatio ...... nst HPV-driven tumors in vivo.
@nl
P2093
P2860
P50
P356
P1476
siRNA-induced immunostimulatio ...... inst HPV-driven tumors in vivo
@en
P2093
Norliana Khairuddin
Sherry Y Wu
Stephen J Blake
P2860
P304
P356
10.1038/ICB.2011.19
P577
2011-03-22T00:00:00Z